Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $219.79, but opened at $214.00. Teleflex shares last traded at $215.72, with a volume of 393,353 shares traded.
Analyst Upgrades and Downgrades
TFX has been the topic of a number of recent research reports. Truist Financial decreased their price objective on Teleflex from $240.00 to $219.00 and set a "hold" rating on the stock in a research report on Friday, May 3rd. Royal Bank of Canada cut their target price on shares of Teleflex from $272.00 to $265.00 and set an "outperform" rating on the stock in a research report on Friday, February 23rd. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research note on Friday, May 3rd. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 23rd. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Teleflex has a consensus rating of "Moderate Buy" and an average price target of $261.75.
Read Our Latest Analysis on TFX
Teleflex Stock Performance
The firm has a market cap of $10.29 billion, a P/E ratio of 35.08, a PEG ratio of 2.01 and a beta of 1.13. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51. The stock's 50-day moving average is $214.35 and its 200 day moving average is $227.47.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 EPS for the quarter, topping analysts' consensus estimates of $3.07 by $0.14. The company had revenue of $737.80 million for the quarter, compared to analyst estimates of $726.85 million. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. Teleflex's revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm posted $3.09 earnings per share. On average, research analysts predict that Teleflex Incorporated will post 13.75 earnings per share for the current year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.62%. Teleflex's dividend payout ratio (DPR) is 21.83%.
Insider Buying and Selling
In other news, VP Cameron P. Hicks sold 7,401 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the sale, the vice president now owns 10,050 shares of the company's stock, valued at $2,261,250. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.43% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in TFX. Allworth Financial LP lifted its stake in Teleflex by 332.3% in the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company's stock valued at $26,000 after purchasing an additional 103 shares during the last quarter. Venturi Wealth Management LLC acquired a new stake in shares of Teleflex in the third quarter valued at approximately $27,000. Covestor Ltd increased its holdings in shares of Teleflex by 305.6% during the 3rd quarter. Covestor Ltd now owns 146 shares of the medical technology company's stock worth $29,000 after acquiring an additional 110 shares during the last quarter. Riverview Trust Co acquired a new position in shares of Teleflex during the 1st quarter worth approximately $31,000. Finally, Lindbrook Capital LLC raised its stake in Teleflex by 75.3% in the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company's stock valued at $34,000 after acquiring an additional 58 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.
Teleflex Company Profile
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
